[Scivita Medical]Scivita Medical was selected as the "List of Potential Unicorn Enterprises in China in 2021"

On June 29, guided by Suzhou Municipal People's Government, and co-sponsored by Suzhou Industrial Park Administrative Committee and Great Wall Strategy Consultants, the report conference on 2021 Chinese potential unicorn enterprises was successfully held, and Scivita Medical Technology (Suzhou) Co., Ltd. (hereinafter referred to as "Scivita Medical") was selected as the "List of Potential Unicorn Enterprises in China in 2021".

Ceremony for certification of potential unicorn enterprises in China

Scivita Medical, which won the list of "Potential Unicorn Enterprises in China", is a platform-based enterprise with globalization as a strategy for innovative products in the fields of endoscopes and related fields, with R&D centers in Suzhou, China and Tokyo, Japan. The product matrix of Scivita Medical covers both flexible endoscopes and rigid endoscopes, and 4K ultra-high definition endoscopic camera system, 3D image imaging device, disposable electronic cystopyeloscope, disposable electronic bronchoscope and disposable electronic hysteroscope have been successively introduced.

The endoscope industry has high technical barriers and integrates many disciplines such as medicine, optics, materials, precision machinery, electronic engineering, and software development. At present, the endoscopic equipment market presents an oligopoly situation, and international brands occupy a large market share by virtue of their preemptive advantages. Scivita Medical has successfully achieved breakthroughs in key fields such as optical imaging and image processing of endoscopes, breaking the technical monopoly of international brand products and having ultra-high resolution imaging technology (such as 4K imaging), 3D imaging technology, special light imaging technology (such as fluorescence imaging), ultra-fine endoscopic imaging technology, and disposable technology.

Scivita Medical "2021 China Potential Unicorn Enterprise" trophy

The potential unicorn enterprise is a new star force with great development potential and growth. Scivita Medical was rated as a potential unicorn enterprise in China in 2021, fully reflecting the recognition and expectation of capital and market for the development potential and enterprise value of Scivita Medical. Scivita Medical will continue innovative development to achieve global competition for high-quality products, benefit more patients, and ultimately help every patient and every family of the patient.